Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study.

Kallmann, Boris A; Tiel-Wilck, Klaus; Kullmann, Jennifer S; Engelmann, Ulrich; Chan, Andrew

Kallmann, Boris A; Tiel-Wilck, Klaus; Kullmann, Jennifer S; Engelmann, Ulrich; Chan, Andrew.

Afiliación

Kallmann BA; Multiple-Sclerosis-Center Bamberg, Bamberg, Germany.
Tiel-Wilck K; Neurologisches Facharztzentrum Berlin, Berlin, Germany, for the NeuroTransData Study Group.
Kullmann JS; Medical Management MS, Medical Affairs, Sanofi-Aventis Deutschland GmbH, Siemensstraße 5b, 63263 Neu-Isenburg, Germany.
Engelmann U; Medical Affairs, Sanofi-Aventis Deutschland GmbH, Neu-Isenburg, Germany.
Chan A; Department of Neurology, Bern University Hospital, University of Bern, Switzerland.

Ther Adv Neurol Disord ; 12: 1756286419835077, 2019.

Article en En | MEDLINE | ID: mdl-30944584

Palabras clave

multiple sclerosis; observational; oral; patient-related outcomes; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Ther Adv Neurol Disord Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google